LC-MS/MS characterization of SOBERANA(R)02, a receptor binding domain-tetanus toxoid conjugate vaccine against SARS-CoV-2
Olivia Martínez, Darielys Santana-Mederos, Satomy Pousa, Jean Pierre Soubal, Arielis Rodríguez‐Ulloa, Pablo E. Ramos‐Bermúdez, Vladimir Besada, Raine Garrido, Paulo C. Carvalho, Michel Batista, Katharina Zetl, Jacek R. Wiśniewski, Tammy Boggiano-Ayo, Yury Valdés-Balbín, Dagmar García-Rivera, , Luis Javier González
This paper characterizes the conjugation sites of a SARS-CoV-2 vaccine using LC-MS/MS and identifies 12 and 18 conjugation sites through different analytical strategies.
PROTEOMICS · Jul 1, 2025Peer-reviewedBiochemistry